Route of administration for illicit prescription opioids: a comparison of rural and urban drug users.
about
Rural, Pregnant, and Opioid Dependent: A Systematic ReviewUnderstanding the rural-urban differences in nonmedical prescription opioid use and abuse in the United StatesA mechanistic investigation of thrombotic microangiopathy associated with IV abuse of Opana ER.The reinforcing and subjective effects of intravenous and intranasal buprenorphine in heroin users.Pain management in primary care: strategies to mitigate opioid misuse, abuse, and diversion.Community-based opioid overdose prevention programs providing naloxone - United States, 2010.Correlates and Consequences of Opioid Misuse among High-Risk Young Adults.Abuse potential, pharmacokinetics, pharmacodynamics, and safety of intranasally administered crushed oxycodone HCl abuse-deterrent controlled-release tablets in recreational opioid users.Prevalence and correlates of nonmedical prescription opioid use among a cohort of sex workers in Vancouver, Canada.Abuse potential of intranasal buprenorphine versus buprenorphine/naloxone in buprenorphine-maintained heroin users.Abuse-deterrent formulations: transitioning the pharmaceutical market to improve public health and safety.Drug use, hepatitis C, and service availability: perspectives of incarcerated rural women.Transition from first illicit drug use to first injection drug use among rural Appalachian drug users: a cross-sectional comparison and retrospective survival analysis.Alternate routes of administration and risk for HIV among prescription opioid abusers.Non-medical use of opioids among HIV-infected opioid dependent individuals on opioid maintenance treatment: the need for a more comprehensive approach.Intravenous melatonin abuse leading to recurrent aortic valve endocarditis: a case report and discussionSocial networks and HCV viraemia in anti-HCV-positive rural drug users.Dynamic model of nonmedical opioid use trajectories and potential policy interventions.Hepatitis C viremia and genotype distribution among a sample of nonmedical prescription drug users exposed to HCV in rural Appalachia.Predictors of transition to heroin use among initially non-opioid dependent illicit pharmaceutical opioid users: A natural history study.Intranasal buprenorphine alone and in combination with naloxone: Abuse liability and reinforcing efficacy in physically dependent opioid abusersPharmacokinetics, tolerability, and safety of intranasal administration of reformulated OxyContin(®) tablets compared with original OxyContin (®) tablets in healthy adults.Update on prescription extended-release opioids and appropriate patient selection.The opiate pain reliever epidemic among U.S. arrestees 2000-2010: regional and demographic variations.Harm reduction for young people who use prescription opioids extra-medically: Obstacles and opportunities.Alternate Routes of Administration among Prescription Opioid Misusers and Associations with Sexual HIV Transmission Risk BehaviorsGender differences in circumstances surrounding first injection experience of rural injection drug users in the United States.Concurrent substance abuse is associated with sexual risk behavior among adults seeking treatment for prescription opioid dependence.Nonmedical prescription drug users in private vs. public substance abuse treatment: a cross sectional comparison of demographic and HIV risk behavior profilesHealth and social problems associated with prescription opioid misuse among a diverse sample of substance-using MSM.Retention of participants in medication-assisted programs in low- and middle-income countries: an international systematic review.Characterization of prescription opioid abuse in the United States: focus on route of administration.Routes of abuse of prescription opioid analgesics: a review and assessment of the potential impact of abuse-deterrent formulations.Heroin use onset among nonmedical prescription opioid users in the club scene.An overview of prodrug technology and its application for developing abuse-deterrent opioids.Prevention knowledge, risk behaviours and seroprevalence among nonurban injectors of southwest ConnecticutThe health consequences of injecting tablet preparations: foreign body pulmonary embolization and pulmonary hypertension among deceased injecting drug users.Rural and urban comparisons of polysubstance use profiles and associated injection behaviors among people who inject drugs in Puerto Rico.Abuse-deterrent formulations of opioid analgesics.Attractiveness of reformulated OxyContin(R) tablets: assessing comparative preferences and tampering potential.
P2860
Q26745439-1761D5BB-4F3C-48D6-A20C-55BCE609DB54Q28396625-6CA3F7A7-582B-4A2E-9F17-6563BCF3D1F2Q33436940-AC42C3EA-780F-4012-B6C8-24026600F0CCQ33889324-DA819FBF-303B-4957-A594-C044DA9230CBQ34176746-EC3D906A-0EBB-4E94-9184-042DC20C8D56Q34254698-36ECACAC-1FC9-442C-A24F-FF2F6DB7B020Q34652214-F1EE862D-8DB9-44D7-81B6-A714F8E784FDQ34677759-B7ACF466-214D-4F8D-8CAB-46D62F9F2832Q34778057-0D904D0B-7680-4DDD-AA4F-419ED5EC552AQ35009760-C9A67DB8-FC84-45F7-8589-969C6CAB2D99Q35528943-E4D799F1-4393-4BB4-B84F-359DD8FF1DB6Q35586252-9E6DF111-7A7F-4C35-80BD-F968EE9401FCQ35683199-78DF76D4-A3A3-4FC0-A3EE-A8D7EF300EBFQ35754791-91415740-D940-4109-9934-000956F2F533Q35777089-3BA6E618-A664-4EB5-89B2-EEA2B841840CQ35934743-C1D1DA5F-1238-4A55-A490-F5693B14253DQ36312926-F362F366-739F-4BE2-B219-E7BF747D28D0Q36389066-562AE4FB-161F-47C2-9015-2D3843AF44A9Q36607811-13ACCF04-87DE-4600-9A5E-D921EC8F3AD7Q36619410-A2054C4C-1F8E-4A56-A2FD-1AEC5EF75527Q36803326-01784A00-D77C-4CB6-A326-A7ED70873141Q36878225-3288B819-D870-4B9E-B273-2C3C921737DAQ37053718-6AAB6E7E-DB49-4F87-AEA4-2E4EB2D34813Q37095195-84B67949-F43C-4DE6-8767-81930AC41C11Q37154709-27C24AB7-8543-4D8E-9BC2-8E1B00509137Q37184992-66EDD604-09BF-4CD0-ACCB-99AB667912B6Q37417649-7435B94A-C4FA-4F04-8FEE-D0CED976500BQ37557620-8A00DE68-757A-4FB9-BE0B-EB2C1FE7382BQ37558785-4ED4F825-34BA-40FB-8D10-DA86B2E7807AQ37626034-07B7ACC1-768E-4B3B-A149-55FC8560A511Q37645900-F4B389F2-48FC-4B68-8942-D08643791A46Q38106987-4CA6463A-0267-4CF9-ACB7-5199ED3D787CQ38632934-78BC22FD-B956-447A-B45B-E258E607B3DDQ38643889-8C4853A4-C93A-4C69-B0D6-108628DE284FQ38651980-66905BF5-3B2E-455E-B1B8-7F2CC07F4442Q39855070-A20F4EA9-2E28-4270-BBA2-56D69377D399Q41161455-8505460D-C0A6-4955-BAA4-5E697B544F3CQ42698813-9F8F0B01-93ED-45CB-B090-D4A04BAE48E2Q43976503-4AB01899-20B6-45FB-8694-77EA4E52178CQ44184161-2B3BAD20-974C-4555-9D45-15DE2C597F70
P2860
Route of administration for illicit prescription opioids: a comparison of rural and urban drug users.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Route of administration for il ...... of rural and urban drug users.
@ast
Route of administration for il ...... of rural and urban drug users.
@en
Route of administration for il ...... of rural and urban drug users.
@nl
type
label
Route of administration for il ...... of rural and urban drug users.
@ast
Route of administration for il ...... of rural and urban drug users.
@en
Route of administration for il ...... of rural and urban drug users.
@nl
prefLabel
Route of administration for il ...... of rural and urban drug users.
@ast
Route of administration for il ...... of rural and urban drug users.
@en
Route of administration for il ...... of rural and urban drug users.
@nl
P2860
P356
P1476
Route of administration for il ...... of rural and urban drug users
@en
P2093
Carl G Leukefeld
P2860
P2888
P356
10.1186/1477-7517-7-24
P577
2010-10-15T00:00:00Z
P5875
P6179
1035365175